InvestorsHub Logo
Followers 82
Posts 3771
Boards Moderated 0
Alias Born 08/08/2006

Re: BillionaireEye post# 13657

Thursday, 10/25/2018 12:17:16 PM

Thursday, October 25, 2018 12:17:16 PM

Post# of 16886
Still a bull sentiment on this stock from the chart technicals standpoint and certainly from a product demand standpoint.

Titan Pharmaceutical Shares Rising After Trump Signs Anti-Opioid Bill -- Market Mover
2:36 pm ET October 24, 2018 (Dow Jones) Print
Shares of South San Francisco-based Titan Pharmaceuticals are rising in Wednesday trading, with the stock gaining 11.46% to 53 1/2 cents at 2:24 p.m. EDT. Volume is very heavy, at 53.1 million shares, well above the 65-day average volume of 4.5 million. The company's lead product is a probuphine implant for the long-term maintenance treatment of opioid dependence. Earlier in the day, President Donald Trump signed an anti-opioid addiction bill which, among other things, allows for the delivery of anti-opioid medicines via injection or implantation. (stephen.nakrosis@wsj.com)

(END) Dow Jones Newswires

“Mankind was my business. The common welfare was my business; charity, mercy, forbearance, benevolence, were all my business. The dealings of my trade were but a drop of water in the comprehensive ocean of my business!"
- Marley's Ghost
Charles Dickens

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News